Market News & Trends
OpenAI Acquires Orchestra Bio to Connect AI Research With Drug Development Workflows
OpenAI has acquired Orchestra Bio, bringing its drug-development program coordination platform into the Rosalind life sciences initiative to connect AI-driven scientific reasoning with the operational work of advancing drug candidates.
Menarini Secures Worldwide Rights to Georgiamune's Experimental Oral Immunotherapy in Deal Worth Up to $1.1B
Menarini Group and Stemline Therapeutics have licensed worldwide rights to Georgiamune’s GIM-621, a preclinical oral immunotherapy for solid tumors, in a deal worth up to $1.1 billion.
TFS HealthScience Repositions Its CRO Offering Around Clinical Trial Continuity and Therapeutic Expertise
TFS HealthScience has introduced a new global brand identity emphasizing clinical trial continuity and therapeutic specialization across its CRO operations in more than 40 countries.
Lilly Invests $5B in Virginia Facility for Advanced Cancer Drug Manufacturing
Eli Lilly has begun construction on a $5 billion manufacturing facility in Goochland County, Virginia, to produce next-generation cancer medicines. The site will integrate API production with finished drug manufacturing for the first time at a Lilly facility.
Former OpenAI Exec Launches Warp Sciences With $215M to Automate Drug Discovery
Former OpenAI executive Kevin Weil has launched Warp Sciences with $215 million in funding to develop an automated approach to optimizing drug candidates. The company will build a highly automated U.S. laboratory combining robotics and AI, with Lightspeed Venture Partners leading the round at an $865 million valuation.
AI Proteins, Astellas Strike Deal to Develop Computationally Designed Therapeutics
AI Proteins and Astellas have signed a research collaboration and licensing agreement to discover computationally designed miniprotein therapeutics. The deal could generate more than $400 million for AI Proteins in upfront and milestone payments, plus royalties.
Zylidac Bio and Prolific Machines Team Up to Advance Light-Controlled Biologics Manufacturing
Zylidac Bio and Prolific Machines have entered into a partnership to advance Prolific’s light-controlled cell line development technology from research into GMP production of complex biologics.
LGM Pharma Expands Analytical Testing Portfolio With Sannova Analytical Acquisition
LGM Pharma has acquired Sannova Analytical, adding specialized GLP bioanalytical testing and impurity analysis capabilities to its U.S. laboratory services business.
Recipharm Adds Sterile Semi-Solid Manufacturing Capacity at Portuguese Site
Recipharm has commissioned a new sterile cream and ointment production line at its Odivelas, Portugal facility, adding 8–15 million units of annual capacity for pharmaceutical companies seeking sterile semi-solid manufacturing.
HUTCHMED Finalizes GSK Deal for Experimental Targeted Cancer Therapy
HUTCHMED has finalized its licensing agreement with GSK for HMPL-A830, an investigational antibody-targeted cancer therapy, with $110 million upfront and up to $1.185 billion in potential milestones.
Roche and Hansoh Expand Oncology Partnership With ADC Deal Worth Over $15B in Potential Milestones
Hansoh Pharmaceutical and Roche have signed an expanded ADC collaboration and licensing agreement covering a portfolio of antibody-drug conjugates, with $400 million upfront and more than $15 billion in potential milestones.
Cosette Secures First NDA Approval With New EVOXAC Oral Formulation
Cosette Pharmaceuticals has received FDA approval for EVOXAC oral solution for dry mouth symptoms in Sjögren’s disease — the company’s first NDA approval from its own product development.
Systech Introduces Integrated Systems to Streamline Pharmaceutical Packaging and Track-and-Trace Operations
Systech has introduced two integrated packaging systems, the ST15S and ST16P, designed to help pharmaceutical manufacturers automate packaging tasks and meet serialization and traceability requirements.
Eppendorf Brings Research Resources to Munich's Emerging Biotech Companies
Eppendorf has extended its collaboration with BioLabs as a Gold Sponsor at BioLabs | TUM in Munich, providing resident life sciences startups with laboratory equipment, software, maintenance, training, and networking opportunities.
Alentra Brand Launch Reflects Currier's Expansion Into Full-Service CDMO Services
Currier has adopted a new name, Alentra, as the company expands its role in contract development and manufacturing across the healthcare and life sciences industries.…
Kindeva Secures $226M Defense Contract for Nerve Agent Antidote Autoinjectors
Kindeva’s global health security division, Meridian Medical Technologies, LLC, has been awarded a contract valued at up to $226 million by the Defense Logistics Agency…
Takara Bio, SPT Labtech Team Up to Automate NGS Library Preparation
Takara Bio USA, Inc. and SPT Labtech have partnered to make next-generation sequencing (NGS) library preparation more accessible to laboratories seeking to scale throughput and…
Revvity Unveils AI-Powered Workflow Platform to Streamline Drug Development and Manufacturing
Revvity has introduced a new software solution designed to coordinate scientific workflows across research, development, and manufacturing, with the goal of reducing operational disconnects that…
ScionxBio, Sanofi Team Up on Long-Acting mRNA Therapies
ScionxBio has entered into a worldwide strategic collaboration and licensing agreement with Sanofi to develop longer-acting versions of selected mRNA therapeutics, combining the French pharmaceutical…
MVIC, Upperton Partner to Streamline Inhaled and Nasal Drug Development
MVIC (Medicon Valley Inhalation Consortium) and Upperton Pharma Solutions have formed a strategic collaboration aimed at simplifying the path from early drug development to clinical…
















